1. Home
  2. PYPD vs RGS Comparison

PYPD vs RGS Comparison

Compare PYPD & RGS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo PolyPid Ltd.

PYPD

PolyPid Ltd.

N/A

Current Price

$5.10

Market Cap

71.7M

Sector

Health Care

ML Signal

N/A

Logo Regis Corporation

RGS

Regis Corporation

N/A

Current Price

$26.79

Market Cap

72.7M

ML Signal

N/A

Company Overview

Basic Information
Metric
PYPD
RGS
Founded
2008
1922
Country
Israel
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Other Consumer Services
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
71.7M
72.7M
IPO Year
2014
1994

Fundamental Metrics

Financial Performance
Metric
PYPD
RGS
Price
$5.10
$26.79
Analyst Decision
Strong Buy
Analyst Count
4
0
Target Price
$12.25
N/A
AVG Volume (30 Days)
169.7K
4.9K
Earning Date
05-06-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
20.24
EPS
N/A
0.89
Revenue
N/A
$210,134,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
$29.81
Revenue Growth
N/A
3.52
52 Week Low
$3.06
$19.31
52 Week High
$5.73
$31.50

Technical Indicators

Market Signals
Indicator
PYPD
RGS
Relative Strength Index (RSI) 58.99 43.45
Support Level $4.18 $25.96
Resistance Level $5.07 $29.10
Average True Range (ATR) 0.25 1.25
MACD 0.06 -0.12
Stochastic Oscillator 83.80 21.25

Price Performance

Historical Comparison
PYPD
RGS

About PYPD PolyPid Ltd.

PolyPid Ltd is a clinical-stage biopharmaceutical company engaged in the research and development of products based on PLEX (Polymer-Lipid Encapsulation MatriX), the company's proprietary drug delivery technology. PLEX is capable of encapsulating many types of drugs to enable targeted, localized drug delivery into the body over extended periods of time with pre-determined release rates thus optimizing drug treatment regimens. BonyPid, PolyPid, Opzifend, Ssisurg, Elyfssi, Baczenssi, Opzifend and Bacyssio are trademarks of the company. The company's product candidate include D-PLEX100 for prevention of SSI in soft tissue and OncoPLEX which can be a potential Intra-tumoral therapy.

About RGS Regis Corporation

Regis Corporation owns, franchises, and operates beauty salons in North America and the U.K., serving mainly price-conscious customers. Its salons, located mostly in strip malls, shopping centers, and Walmart stores, offer services like haircutting, styling, shampooing, conditioning, and hair coloring, along with hair care and beauty products. The company's primary brands include Supercuts, SmartStyle, and Cost Cutters. Regis generates the majority of its revenue from these mass-market locations and reports operations in two segments: franchise and company-owned, with services making up about 94% of company-owned salon sales.

Share on Social Networks: